top of page

Our Mission

VosBio is dedicated to expanding respiratory research and discovery through our innovative analytical approach to biological problems. By using an analytical approach, our technology is usable, practical and predictable. Our mission is to provide cutting-edge technologies for enhanced diagnostics and research in the field of respiratory health. Exhaled breath is a non-invasive, comfortable sample that contains the primary source of respiratory infectiousness. In Spiritu Veritas; Truth is in Breath.

Disintegrating Sphere_edited.jpg
Disintegrating Sphere_edited_edited.png

Our Story

Founded in 2020 during the Covid-19 pandemic, testing for SARS-CoV-2 was widespread as was a shortage of spin columns to perform the needed purification of clinical samples. Co-founder Doug Gjerde sought a solution for the shortage of spin columns needed to process clinical samples. 

​

At the heart of the collection process is VosBio™ Universal Breath Collector. Our device allows for the collection of exhaled breath condensate (EBC) in a fast and efficient way that is as easy as breathing. 

​

Our collection method allows users to directly analyze the clinical sample without the need to purify the sample using spin columns using our proprietary chemistry. This analytical approach also looks at the source of respiratory disease.​​

​

Exhaled Breath Condensate is a biological sample that includes organic, protein, and nucleic acid biomarkers. Our Universal Breath Collector approach efficiently captures both condensate and droplets that inculde organic compounds. These can be used to detect infection and inflammation; leading causes of lung damage in chronic respiratory disease. We call this the comprehensive approach.

 

As a result of this work, we now have a system that can be used to investigate any respiratory illness using any detection method. This includes PCR, mass spectrometry, pH, UV spectrometry, ELISA and others.

Support Team 

Daniel Beal

VosBio - R&D, Manufacturing and Media

DBeal.jpg

Alejandro Yañez

PCR Assay development and optimization, primer design and data analysis

AYanez.jpg

Management Team 

VosBio’s leadership team combines deep scientific innovation with decades of experience in company formation, capital strategy, and scaling successful enterprises. The team has a proven track record of building and exiting high-impact companies and is focused on advancing non-invasive diagnostics through breakthrough breath-based technologies.

Doug-600x800.jpg

Douglas T. Gjerde, Ph.D

Co-Founder, Chief Executive Officer, Chief Scientific Officer, and Board Member

CLICK for Doug's Bio

Gary Patterson

Co-Founder, Chief Financial Officer, and Board Member

CLICK for Gary's Bio

Gary-600x800.jpg

Perry Olson, J.D.

Co-Founder and Board Member

CLICK for Perry's Bio

Perry-600x800.jpg

Scientific Advisory Board

The VosBio Scientific Advisory Board brings together a diverse group of accomplished scientists and technical experts spanning biology, chemistry, engineering, and clinical research. By integrating expertise in areas such as molecular biology, analytical chemistry, mass spectrometry, and disease pathology, the board is uniquely positioned to guide the development of VosBio’s technology from fundamental science through translational application.

Carl Smythe, Ph.D.

University of Sheffield

CLICK for Carl's Bio

Carl-Smythe-600x800.jpg

Dave Hornby, Ph.D.

University of Sheffield

Dave-Hornby-600x800.jpg

Dennis Burton, Ph.D.

Scripps Research Institute

CLICK for Dennis's Bio

Dennis-B-600x800.jpg

Daniel Bollinger

VosBio, Head of Research & Business Development

CLICK for Dan's Bio

Daniel-Bollinger-600x800.jpg
bottom of page